Çölyak hastalığı (ÇH) oldukça sık görülen bir hastalıktır. Klasik ÇH küçük yaşlarda ortaya çıkarken, atipik hastalık büyük çocuklarda ortaya çıkma eğilimindedir. Değişik klinik bulgular ve tanı- tarama yöntemleri hakkındaki bilgi birikimin artması hastalıktan etkilenen çocukların erken tanı almasına ve uygun müdahalesine olanak sağlamıştır. Serolojik testler daha güvenilir hale gelmesine rağmen, özellikle 2 yaş altındaki çocuklarda testlerle ilgili sorunlar devam etmektedir. Çölyak hastalarının büyük bir kısmı HLA DQ2 veya DQ8 kodlayan genleri taşırlar. Bu genlerin negatifliği ÇH olasılığını dışlamak için yararlı olabilir. Çölyak hastalığına tanı koymak için Glutensiz diyet başlanmadan önce, gluten içeren diyet altında duodenal biyopsi yapılmalıdır. Glutensiz diyet asemptomatik olan hastalar da dahil ÇH tanısı alan tüm çocuklara verilmelidir.
Celiac disease is extremely common. The classical presentation tends to occur in younger children, while atypical presentations occur at an older age. Knowledge about the varied clinical manifestations together with CD screening and diagnosis lead to appropriate early diagnosis and intervention in affected children. Although serologic testing has become more reliable, there still remain significant problems with testing, particularly in children under 2 years old. Genes encoding HLA DQ2 or DQ8 are found in the vast majority of those with CD, and negative test results can be useful in ruling out the disorder. All patients should undergo a duodenal biopsy while on a gluten-containing diet in order to diagnose CD before a gluten-free diet (GFD) is recommended. A GFD should be offered to all children diagnosed with CD even when perceived as asymptomatic
Other ID | JA72ZT77CT |
---|---|
Journal Section | Collection |
Authors | |
Publication Date | August 1, 2014 |
Submission Date | August 1, 2014 |
Published in Issue | Year 2014 Volume: 8 Issue: 2 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 6 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.